Garcia-Bournissen Facundo (Facundo Garcia-Bournissen, Facundo García Bournissen, Facundo Garcia Bournissen)

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Venues

British journal of clinical pharmacology

PLoS neglected tropical diseases

Journal of paediatrics and child health

Expert review of clinical pharmacology

Londons Health Sciences Centre, Schulich School of Medicine & Dentistry, University of Western Ontario

University of Toronto (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Londons Health Sciences Centre, Schulich School of Medicine & Dentistry, University of Western Ontario Aug 01 2019

Canada

Clinician Researcher, Associate Professor :: Division of Pediatric Clinical Pharmacology, Department of Pediatrics

Consejo Nacional de Investigaciones Cientificas y Tecnicas

Argentina

Independent Researcher :: IMIPP (Multidisciplinary Institute for Research on Pediatric Diseases). Parasitology and Chagas Service, Buenos Aires Children's Hospital "Ricardo Gutierrez"

Education History

University of Toronto

Canada

PHD :: Institute of Medical Sciences

Publications

Cintia Valeria Cruz, Andres Rabinovich, Guillermo Moscatelli, Samanta Moroni, Nicolas González, Garcia-Bournissen Facundo, Griselda Ballering, Hector Freilij, Fernanda Lascano
Adverse events associated with benznidazole treatment for Chagas disease in children and adults. British journal of clinical pharmacology (2024)
Yanina Hiriart, Paula Scibona, Augusto Ferraris, Waldo H Belloso, Valeria Beruto, Garcia-Bournissen Facundo, Vanesa Zylberman, Luciana Muñoz, Fernando Goldbaum, Linus Spatz, Mariana Colonna, Santiago Sanguineti, Ventura A Simonovich
A phase I study to evaluate the safety, tolerance and pharmacokinetics of anti-Shiga toxin hyperimmune equine F (ab') 2 fragments in healthy volunteers. British journal of clinical pharmacology 90 (4) (2024)
Yanina Hiriart, Paula Scibona, Augusto Ferraris, Waldo H Belloso, Valeria Beruto, Garcia-Bournissen Facundo, Vanesa Zylberman, Luciana Muñoz, Fernando Goldbaum, Linus Spatz, Mariana Colonna, Santiago Sanguineti, Ventura A Simonovich
A phase I study to evaluate the safety, tolerance and pharmacokinetics of anti-Shiga toxin hyperimmune equine F (ab') 2 fragments in healthy volunteers. British journal of clinical pharmacology 90 (4) (2024)
Yanina Hiriart, Paula Scibona, Augusto Ferraris, Waldo H Belloso, Valeria Beruto, Garcia-Bournissen Facundo, Vanesa Zylberman, Luciana Muñoz, Fernando Goldbaum, Linus Spatz, Mariana Colonna, Santiago Sanguineti, Ventura A Simonovich
A phase I study to evaluate the safety, tolerance and pharmacokinetics of anti-Shiga toxin hyperimmune equine F (ab') 2 fragments in healthy volunteers. British journal of clinical pharmacology (2024)
Lucas Brstilo, Gabriela Reyes Valenzuela, Roberto Caraballo, Carlos Pérez Montilla, Garcia-Bournissen Facundo, Paulo Caceres Guido, Paula S Schaiquevich
Real-World Evidence of Factors Affecting Cannabidiol Exposure in Children with Drug-Resistant Developmental and Epileptic Encephalopathies. Pharmaceutics 15 (8) (2023)
Natalie M Zitoun, M Karen Campbell, Doreen Matsui, Garcia-Bournissen Facundo
Prospective Evaluation of Pregnancy Outcomes after Gestational Exposure to Prazosin. British journal of clinical pharmacology (2023)
Kiersten A Amos, Garcia-Bournissen Facundo, Liena Zhao, Sepideh Taheri
Carbamazepine-induced liver injury in an 11-year-old female: Case report and review of the literature. Journal of paediatrics and child health (2022)
Micol Romano, Garcia-Bournissen Facundo, David Piskin, Ulkumen Rodoplu, Lizzy Piskin, Abdelbaset A Elzagallaai, Tunc Tuncer, Siren Sezer, Didar Ucuncuoglu, Tevfik Honca, Dimitri Poddighe, Izzet Yavuz, Stenvinkel Peter, Mahmut Ilker Yilmaz, Erkan Demirkaya
Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Study. Life (Basel, Switzerland) 12 (6) (2022)
Amandine Remy, Thai Hoa Tran, Josée Dubois, Paul Gavra, Chantal Lapointe, Rochelle Winikoff, Garcia-Bournissen Facundo, Yves Théorêt, Niina Kleiber
Repurposing alpelisib, an anti-cancer drug, for the treatment of severe TIE2-mutated venous malformations: Preliminary pharmacokinetics and pharmacodynamic data. Pediatric blood & cancer 69 (10) (2022)
Michael J Rieder, Garcia-Bournissen Facundo
Paediatric and obstetrical pharmacology - Pushing the frontier forward. British journal of clinical pharmacology 88 (10) (2022)
Ethel D Weld, Catriona Waitt, Karen I Barnes, Garcia-Bournissen Facundo
Twice neglected? Neglected diseases in neglected populations. British journal of clinical pharmacology (2021)
Luciana Noemi García, Alejandra Destito Solján, Samanta Moroni, Nicolas Falk, Nicolás Gonzalez, Guillermo Moscatelli, Griselda Ballering, Garcia-Bournissen Facundo, Jaime M Altcheh
Congenital syphilis in Argentina: Experience in a pediatric hospital. PLoS neglected tropical diseases 15 (1) (2021)
Dimitri Poddighe, Micol Romano, Garcia-Bournissen Facundo, Erkan Demirkaya
Conventional and novel therapeutic options in children with familial Mediterranean fever: A rare autoinflammatory disease. British journal of clinical pharmacology (2021)
Jadel Müller Kratz, Garcia-Bournissen Facundo, Colin J Forsyth, Sergio Sosa-Estani
Clinical and pharmacological profile of benznidazole for treatment of Chagas disease. Expert review of clinical pharmacology 11 (10) (2018)

Garcia-Bournissen Facundo.css-eqlu8i{font-size:small;padding-left:4px;} (Facundo Garcia-Bournissen, Facundo García Bournissen, Facundo Garcia Bournissen)

Publication Activity (10 Years)

Top Topics

Top Venues

Garcia-Bournissen Facundo (Facundo Garcia-Bournissen, Facundo García Bournissen, Facundo Garcia Bournissen)